Elevance Health Inc. Common Stock vs Invesco Ltd. — how do they compare? Elevance Health Inc. Common Stock trades at $411.65 (market cap $86.95B), while Invesco Ltd. trades at $29.52 (market cap $13.28B). The key difference: Elevance Health Inc. Common Stock is far larger — about 6.5× Invesco Ltd.'s market cap, and Invesco Ltd. pays the higher dividend (2.86%). Which is the better fit depends on your goals.
| ELV | IVZ | |
|---|---|---|
Market Cap | $86.95B | $13.28B |
Volume | 782,706 | 3,698,033 |
Sector | Health | Financials |
52-Week High | $426.79 | $33.31 |
52-Week Low | $280.74 | $22.44 |
Enterprise Value | $107.76B | $23.45B |
Dividend Yield | 1.72% | 2.86% |
Typical Hold Time | — | 77 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Invesco (IVZ) trades at $29.51, down 3.25% today, with bearish technical signals dominating. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026, while Q3 2026 results are pending. Despite negative net income margins in 2025, operating cash flow remains strong at $1.53 billion, and analyst consensus leans toward Hold with a $33.71 price target. Recent news highlights ETF expansions and AUM growth to $2.56 trillion in August 2026.
The outlook is cautious; IVZ faces profitability challenges with negative ROE and net margins, but solid cash flow and analyst buy ratings (42.86%) suggest recovery potential. Risks include earnings volatility and competitive ETF pressures, while institutional sentiment is neutral. The stock's current price near the low end of analyst targets ($28-$41) may appeal to value investors betting on operational improvements.
Trailing returns across standard periods
Latest headlines on both assets
Elevance Health provides health plans and healthcare services. Its offerings include medical, behavioral health, pharmacy, dental, vision, and complex-care solutions, including through the Carelon business.
Read more on ELV →Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →